Insights

Large TAM Freeneome has already secured over $1.5B in funding and boasts a revenue range of $100M-$250M with a high-growth trajectory, indicating a sizable total addressable market in cancer screening and strong validation for potential partnerships with payers, pharma, and diagnostics distributors.

Strategic Partnerships Recent FDA breakthrough designation for SimpleScreen Lung and an out-license arrangement of SimpleScreen CRC with Abbott present clear co-development and commercial collaboration opportunities. Partnerships with insurers, pharma, and medical device companies could accelerate adoption and reimbursement.

Multiomics Advantage Freeneome’s multiomics platform combined with machine learning enables detection across multiple cancers from a single blood draw, creating a scalable value proposition for joint selling with existing clinicians, screening programs, and integrated healthcare delivery systems.

Expanded Screening Launch of SimpleScreen Lung and the bundled option for simultaneous lung and colorectal screening via a single draw opens cross-sell opportunities with primary care networks, pulmonology, gastroenterology, and large employer health programs seeking convenient, comprehensive screening.

Commercial Readiness FDA approval for colorectal cancer screening and upcoming PROACT LUNG studies signal near-term revenue catalysts; sales efforts should target health systems, payer negotiations, and distributors to maximize adoption of approved tests and capitalize on milestone-based payments and royalties.

Similar companies to Freenome

Freenome Tech Stack

Freenome uses 8 technology products and services including Twitter Ads, Looker, Apache Spark, and more. Explore Freenome's tech stack below.

Media & News

Freenome's Email Address Formats

Freenome uses at least 4 email formats:
Freenome Email FormatsExamplePercentage
First.Last@freenome.comJohn.Doe@freenome.com
95%
First@freenome.comJohn@freenome.com
3%
FLast@freenome.comJDoe@freenome.com
1%
First.Middle@freenome.comJohn.Michael@freenome.com
1%

Frequently Asked Questions

What is Freenome's phone number?

Minus sign iconPlus sign icon
You can contact Freenome's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Freenome's stock symbol?

Minus sign iconPlus sign icon
Freenome is a publicly traded company; the company's stock symbol is FRNM.

What is Freenome's official website and social media links?

Minus sign iconPlus sign icon
Freenome's official website is freenome.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Freenome generate?

Minus sign iconPlus sign icon
As of October 2026, Freenome's annual revenue is estimated to be $100M - $250M.

What is Freenome's SIC code and NAICS code?

Minus sign iconPlus sign icon
Freenome's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Freenome have currently?

Minus sign iconPlus sign icon
As of October 2026, Freenome has approximately 414 employees across 4 continents, including North America, Europe and Asia. Key team members include Chief Legal Officer: T. F., Chief Financial Officer: L. H. L. and Chief Operating Officer: J. E. Explore Freenome's employee directory with LeadIQ.

What industry does Freenome belong to?

Minus sign iconPlus sign icon
Freenome operates in the Biotechnology Research industry.

What technology does Freenome use?

Minus sign iconPlus sign icon
Freenome's tech stack includes Twitter Ads, Looker, Apache Spark, Amazon Web Services, Prometheus, GitLab, Boomi and Wrike.

What is Freenome's email format?

Minus sign iconPlus sign icon
Freenome's email format typically follows the pattern of First.Last@freenome.com. Find more Freenome email formats with LeadIQ.

How much funding has Freenome raised to date?

Minus sign iconPlus sign icon
As of October 2026, Freenome has raised $1.5B in funding. The last funding round occurred on Nov 17, 2025 for $50M.

When was Freenome founded?

Minus sign iconPlus sign icon
Freenome was founded in 2014.
Freenome logo

Freenome

Biotechnology ResearchCalifornia, United States201-500 Employees

Freenome is a Brisbane, California-based biotechnology research company founded in 2014. It develops blood-based tests intended to identify cancer at its earliest, most treatable stages by integrating data from multiple biological layers with advanced analytics. The company's initial focus is a screening test aimed at detecting early-stage colorectal cancer and related precancerous lesions known as advanced adenomas.

Freenome operates in the biotechnology research sector, seeking to provide tools that enable prevention, early detection, and treatment decisions. In November 2025, the company announced the appointment of Rob Guigley as chief commercial officer, a leadership update reflecting ongoing organizational development.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
FRNM
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
201-500

Section iconFunding & Financials

  • $1.5B

    Freenome has raised a total of $1.5B of funding over 12 rounds. Their latest funding round was raised on Nov 17, 2025 in the amount of $50M as a Corporate Round.

  • $100M - $250M

    Freenome's revenue is estimated to be in the range of $100M - $250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.